Therefore, higher levels of galectins in sera from cancer patients and increased expression of MUC1 and TF antigen-associated MUC1 by cancer cells might enhance molecular interactions between circulating galectins and TF/MUC1, promoting tumor cell adhesion to vascular endothelium and metastasis (222) (Fig. 6). The gene discussed is MUC1; the disease is cancer.